Transcat Inc
NASDAQ:TRNS

Watchlist Manager
Transcat Inc Logo
Transcat Inc
NASDAQ:TRNS
Watchlist
Price: 57.16 USD 0.76% Market Closed
Market Cap: 533.3m USD

Transcat Inc
Investor Relations

Transcat, Inc. engages in provision of calibration and laboratory instrument services. The company is headquartered in Rochester, New York and currently employs 765 full-time employees. Transcat is focused on providing services and products to the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses. Transcat operates through two segments: Service and Distribution. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. Its distribution segment it sells and rent national and brand instruments to customers globally. Its other industries served includes industrial manufacturing; energy and utilities, including oil and gas; chemical manufacturing; FAA-regulated businesses, including aerospace and defense and other industries.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Nov 3, 2025
AI Summary
Q2 2026

Strong Revenue Growth: Transcat reported second quarter revenue of $82.3 million, up 21% year-over-year, with double-digit growth in both service and distribution segments.

Margin Expansion: Consolidated gross margin expanded by 120 basis points and distribution gross margin jumped 530 basis points, mainly due to a higher mix of rental revenue.

Adjusted EBITDA: Adjusted EBITDA rose 37% to $12.1 million, with 160 basis points of margin expansion, reflecting strong operating leverage.

Service Segment Resilience: Service revenue grew 20% and marked the 66th consecutive quarter of year-over-year growth, though organic growth is currently low single digits.

Acquisition Success: Recent acquisitions (Essco and Martin Calibration) are performing above expectations with double-digit growth and smooth integrations.

Outlook: Management continues to expect a return to high single-digit organic service growth and further margin expansion in the second half, based on recently won accounts and improving customer momentum.

Headwinds Noted: Net income declined due to higher interest expense, tax rate, and CEO succession costs; management acknowledges macroeconomic and customer decision delays but remains optimistic.

Key Financials
Revenue
$82.3 million
Distribution Revenue
$29.4 million
Gross Profit
$26.8 million
Distribution Gross Profit
$9.8 million
Net Income
$1.3 million
Diluted Earnings Per Share
$0.14
Adjusted Diluted Earnings Per Share
$0.44
Adjusted EBITDA
$12.1 million
Total Debt
$111.9 million
Available Borrowings
$38.1 million
Leverage Ratio
2.25x
Earnings Call Recording
Other Earnings Calls

Management

Mr. Lee D. Rudow
President, CEO & Director
No Bio Available
Mr. Thomas L. Barbato
CFO & Treasurer
No Bio Available
Ms. Theresa A. Conroy
Senior Vice President of Human Resources
No Bio Available
Mr. Michael W. West
Chief Operating Officer
No Bio Available
Mr. Scott D. Deverell
Corporate Controller & Principal Accounting Officer
No Bio Available
Ms. Marcy Bosley
Vice President of Sales
No Bio Available

Contacts

Address
NEW YORK
Rochester
35 Vantage Point Dr
Contacts
+15853527777.0
www.transcat.com